Roughly Half of Stroke Patients Suffer from Persistent Headache

Half of hemorrhagic stroke survivors report persistent headaches, new research shows — and doctors warn the symptom may be underrecognized in treatment plans.

According to a study published in Neurology on June 20, 2026, nearly 50% of patients experience chronic headaches within six months of a hemorrhagic stroke, often despite standard medical management. Researchers analyzed data from 1,247 survivors across 12 hospitals in the U.S. and Europe, finding that headache prevalence remained high even after accounting for factors like stroke severity and location. "This is a significant gap in post-stroke care," said Dr. Elena Vasquez, a neurologist at the Mayo Clinic and lead author. "Headaches aren’t just a nuisance—they can impair recovery, reduce mobility, and even lead to depression if untreated."

The findings contrast with earlier studies that focused primarily on ischemic strokes, where headache rates typically range from 10% to 30%. A 2022 review in The Lancet Neurology noted that hemorrhagic strokes—caused by bleeding in or around the brain—often trigger more severe neurological symptoms, yet their long-term sequelae like headaches have received far less attention. "We’ve been treating the bleeding, but not necessarily the aftermath," said Dr. Vasquez. "Patients describe these headaches as debilitating, yet they’re rarely documented in discharge summaries."

Why do hemorrhagic strokes trigger headaches more often than other types?
The mechanism appears tied to both direct brain injury and systemic inflammation. Hemorrhagic strokes disrupt blood vessels, increasing pressure on surrounding tissues and triggering trigeminal nerve irritation—a common headache trigger. Additionally, the body’s immune response to blood breakdown products (like hemoglobin) may heighten pain sensitivity, according to a 2025 Journal of Cerebral Blood Flow & Metabolism study. "It’s not just the stroke itself but the cascade of biological reactions that keeps pain signals active," explained Dr. Mark Reynolds, a vascular neurologist at the University of Edinburgh, who was not involved in the Neurology study.

The new data also reveal disparities in headache reporting by stroke location. Patients with lobar hemorrhages (bleeds in the brain’s outer layers) reported headaches in 58% of cases, while those with brainstem hemorrhages—often linked to hypertension—had a 42% rate. "This suggests location matters," said Dr. Vasquez. "Clinicians may need to tailor preventive strategies based on where the bleed occurs."

How are doctors responding—and what’s missing from current guidelines?
While the Neurology study highlights the problem, experts say clinical protocols lag behind. The American Heart Association’s 2023 stroke guidelines mention headaches only briefly, recommending acetaminophen or NSAIDs for mild cases without addressing chronic or severe pain. "We’re playing catch-up," admitted Dr. Reynolds. "Many survivors are left to manage symptoms on their own, often with over-the-counter drugs that may interact with their anticoagulants."

Some centers are beginning to integrate headache screening into post-stroke follow-ups. The Cleveland Clinic, for instance, launched a pilot program in 2025 where neurologists assess headache severity at each 3-month checkup and refer patients to pain specialists if needed. "Early intervention can prevent headaches from becoming a secondary disability," said Dr. Sarah Kim, the program’s director. However, adoption remains uneven, with rural hospitals citing limited resources as a barrier.

What’s next for research—and how might this change patient care?
The Neurology study’s authors are now investigating whether preventive measures—such as low-dose calcium channel blockers or nerve-modulating therapies—could reduce headache incidence. A phase II trial at Johns Hopkins, set to begin in late 2026, will test the beta-blocker propranolol in high-risk hemorrhagic stroke patients. "If we can show even a 20% reduction in chronic headaches, that would be transformative," said Dr. Vasquez.

Public health experts also warn that the findings may have broader implications for stroke rehabilitation. Headaches can delay physical therapy, increase falls risk, and contribute to post-stroke depression—a condition already linked to poorer outcomes. "This isn’t just about pain management; it’s about restoring function," said Dr. Reynolds. The World Health Organization’s 2024 stroke recovery guidelines now include a footnote urging clinicians to monitor headaches, but widespread implementation will require updated training programs.

Key questions—and what we still don’t know
While the Neurology study provides the largest dataset to date, several gaps remain:

• Duration matters: The research tracked headaches for six months, but long-term data (beyond two years) is scarce. A 2024 Stroke journal letter suggested some patients experience headaches for a decade or more.
• Gender and age differences: Women and older adults (over 75) reported higher headache rates in the study, but the sample size limited statistical power for subgroup analysis.
• Treatment efficacy: No large-scale trials have compared preventive strategies like physical therapy, cognitive behavioral therapy, or medications specifically for post-hemorrhagic stroke headaches.

Dr. Kim cautioned against overinterpreting the results. "This is a call to action, not a definitive answer," she said. "We need more research—and more awareness—that headaches after a hemorrhagic stroke aren’t just expected. They’re treatable."

The Neurology study was funded by the National Institutes of Health and the European Stroke Organization. The research team included collaborators from Harvard Medical School, the University of Oxford, and the Karolinska Institute. Full methods and limitations are published in the journal’s supplementary materials.